Literature DB >> 1941118

Morphological study of clinically nonsecreting pituitary adenomas in patients under 40 years of age.

S Yamada1, K Kovacs, E Horvath, T Aiba.   

Abstract

Clinically nonsecreting pituitary adenomas removed at surgery from 69 patients under 40 years of age were studied by histological, immunocytochemical, and transmission electron microscopic examination. By morphological analysis, 19 tumors were found to be null-cell adenomas, 17 silent gonadotroph adenomas, 14 silent subtype 3 adenomas of unknown cellular origin, 13 silent subtype 1 or subtype 2 corticotroph adenomas, three oncocytomas, and three silent thyrotroph adenomas. These results indicate that the incidence of null-cell adenomas and oncocytomas, which are known to be the most common types of nonsecreting pituitary adenomas in patients over 40 years of age, is relatively low in younger patients. This trend is even more obvious in patients younger than 30 years of age. It can be concluded that clinically nonsecreting pituitary adenomas represent a heterogeneous group morphologically, and that the incidence of the different tumor types varies depending on the patient's age. These findings underline the importance of careful morphological studies. It is proposed that, in order for the correct morphological diagnosis to be made, tumors removed surgically from patients with clinically nonsecreting pituitary adenomas (especially younger patients) should be investigated not only by histological means but also by immunocytochemical and electron microscopic examination. The information obtained from such analysis may be useful in assessing prognosis and deciding on the appropriate treatment.

Entities:  

Mesh:

Year:  1991        PMID: 1941118     DOI: 10.3171/jns.1991.75.6.0902

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes.

Authors:  Yuichi Nagata; Naoko Inoshita; Noriaki Fukuhara; Mitsuo Yamaguchi-Okada; Hiroshi Nishioka; Takeo Iwata; Katsuhiko Yoshimoto; Shozo Yamada
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

2.  Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.

Authors:  James A Balogun; Eric Monsalves; Kyle Juraschka; Kashif Parvez; Walter Kucharczyk; Ozgur Mete; Fred Gentili; Gelareh Zadeh
Journal:  Endocr Pathol       Date:  2015-03       Impact factor: 3.943

3.  HORMONAL MARKERS IN THE STUDY OF PITUITARY ADENOMAS.

Authors:  J R Bhardwaj; T Somanathan; Harsh Kumar; P Sivadas; P S Reddy
Journal:  Med J Armed Forces India       Date:  2017-06-26

4.  A silent follicle-stimulating hormone-producing pituitary adenoma in a teenage male.

Authors:  Hiroyuki Tamiya; Noriaki Fukuhara; Naohiro Yoshida; Hisanori Suzuki; Akira Takeshita; Naoko Inoshita; Hiroshi Nishioka; Yasuhiro Takeuchi; Toshiaki Sano; Shozo Yamada
Journal:  Endocr Pathol       Date:  2011-12       Impact factor: 3.943

5.  GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data.

Authors:  A Münscher; M Schmid; W Saeger; S Schreiber; D K Lüdecke
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

6.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

7.  Pituitary hemorrhage : classification and related factors.

Authors:  Dae-Jin Kim; Young-Jin Song; Su-Jin Kim; Mi-Kyoung Park; Sun-Seob Choi; Ki-Uk Kim
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31

8.  Pituitary macroadenoma with persisting dense lymphocytic infiltration in a young male patient.

Authors:  E Cakir; C Bayindir; P A Sabanci; M Imer; N C Ozbey
Journal:  Clin Neuropathol       Date:  2011 Nov-Dec       Impact factor: 1.368

9.  Pharmacoeconomic aspects of the treatment of pituitary gland tumours.

Authors:  Jerzy Sowiński; Nadia Sawicka; Katarzyna Piątek; Ariadna Zybek; Marek Ruchała
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

10.  Pituitary oncocytoma presenting as Cushing's disease.

Authors:  M K Garg; Reena Bharwaj; H C Pathak; Sandeep Kharb; Abhay Gundgurthi; Aditi Pandit; K S Brar
Journal:  Indian J Endocrinol Metab       Date:  2013-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.